Role of adjuvant systemic therapy in high-risk renal cell carcinoma

Aydogdu, C; Casuscelli, J

Aydogdu, C (通讯作者),Ludwig Maximilians Univ Munchen, Urol Klin Poliklin & Klinikum, Marchioninistr 15, D-81377 Munich, Germany.

ONKOLOGIE, 2023; 29 (7): 622

Abstract

Background: Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGF TKIs) and immune checkpoint inhibitors (ICIs) have been shown......

Full Text Link